XDJP.L vs. XGEN.DE

Last updated Jun 5, 2026

XDJP.L (Xtrackers Nikkei 225 UCITS ETF 1D) and XGEN.DE (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) are both exchange-traded funds - XDJP.L is a Japan Equities fund tracking the TOPIX TR JPY, while XGEN.DE is a Health & Biotech Equities fund tracking the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. Both are passively managed. Over the past 3 years, XDJP.L returned 20.95%/yr vs 1.54%/yr for XGEN.DE. At a 0.38 correlation, their price movements are largely independent. XDJP.L charges 0.09%/yr vs 0.30%/yr for XGEN.DE.

Performance

XDJP.L vs. XGEN.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Xtrackers Nikkei 225 UCITS ETF 1D (XDJP.L) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

XDJP.L is traded in GBp, while XGEN.DE is traded in EUR. To make them comparable, the XGEN.DE values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, XDJP.L achieves a 31.98% return, which is significantly higher than XGEN.DE's -2.18% return.

XDJP.L

• 1D: -1.35%
• 1M: 10.95%
• YTD: 31.98%
• 6M: 29.24%
• 1Y: 64.30%
• 3Y*: 20.95%
• 5Y*: 12.61%
• 10Y*: 13.14%

XGEN.DE

• 1D: 4.05%
• 1M: 6.69%
• YTD: -2.18%
• 6M: -4.71%
• 1Y: 25.68%
• 3Y*: 1.54%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

XDJP.L vs. XGEN.DE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
XDJP.L Xtrackers Nikkei 225 UCITS ETF 1D	31.98%	21.04%	9.67%	15.52%	0.23%
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C	-2.18%	12.97%	-1.53%	-7.72%	-6.55%

Correlation

The correlation between XDJP.L and XGEN.DE is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.34
Correlation (3Y) Calculated over the trailing 3-year period	0.39
Correlation (All Time) Calculated using the full available price history since Jul 20, 2022	0.38

Return for Risk

XDJP.L vs. XGEN.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XDJP.L

XDJP.L Risk / Return Rank: 84
XDJP.L Sharpe Ratio Rank: 87
XDJP.L Sortino Ratio Rank: 87
XDJP.L Omega Ratio Rank: 81
XDJP.L Calmar Ratio Rank: 86
XDJP.L Martin Ratio Rank: 77

XGEN.DE

XGEN.DE Risk / Return Rank: 32
XGEN.DE Sharpe Ratio Rank: 35
XGEN.DE Sortino Ratio Rank: 36
XGEN.DE Omega Ratio Rank: 32
XGEN.DE Calmar Ratio Rank: 30
XGEN.DE Martin Ratio Rank: 26

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XDJP.L vs. XGEN.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Xtrackers Nikkei 225 UCITS ETF 1D (XDJP.L) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	XDJP.L	XGEN.DE	Difference
Sharpe ratio: Return per unit of total volatility	2.85	1.41	+1.44
Sortino ratio: Return per unit of downside risk	3.94	2.08	+1.86
Omega ratio: Gain probability vs. loss probability	1.48	1.24	+0.24
Calmar ratio: Return relative to maximum drawdown	4.77	1.66	+3.11
Martin ratio: Return relative to average drawdown	14.50	4.04	+10.46
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

XDJP.L vs. XGEN.DE - Sharpe Ratio Comparison

The current XDJP.L Sharpe Ratio is 2.85, which is higher than the XGEN.DE Sharpe Ratio of 1.41. The chart below compares the historical Sharpe Ratios of XDJP.L and XGEN.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	XDJP.L	XGEN.DE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.85	1.41	+1.44
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.71	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.78	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.75	-0.09	+0.84

Drawdowns

XDJP.L vs. XGEN.DE - Drawdown Comparison

The maximum XDJP.L drawdown since its inception was -23.69%, smaller than the maximum XGEN.DE drawdown of -36.84%. Use the drawdown chart below to compare losses from any high point for XDJP.L and XGEN.DE.

Drawdown Indicators

	XDJP.L	XGEN.DE	Difference
Max Drawdown Largest peak-to-trough decline	-23.69%	-36.84%	+13.15%
Max Drawdown (1Y) Largest decline over 1 year	-13.40%	-15.42%	+2.02%
Max Drawdown (3Y) Largest decline over 3 years	-18.82%	-26.91%	+8.09%
Max Drawdown (5Y) Largest decline over 5 years	-20.61%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-23.69%	—	—
Current Drawdown Current decline from peak	-1.35%	-12.67%	+11.32%
Average Drawdown Average peak-to-trough decline	-6.79%	-17.93%	+11.14%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.42%	6.34%	-1.92%

Volatility

XDJP.L vs. XGEN.DE - Volatility Comparison

Xtrackers Nikkei 225 UCITS ETF 1D (XDJP.L) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) have volatilities of 6.75% and 6.71%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XDJP.L	XGEN.DE	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.75%	6.71%	+0.04%
Volatility (6M) Calculated over the trailing 6-month period	17.68%	14.03%	+3.65%
Volatility (1Y) Calculated over the trailing 1-year period	22.44%	18.18%	+4.26%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.72%	18.48%	-0.76%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.63%	18.48%	-0.85%

XDJP.L vs. XGEN.DE - Expense Ratio Comparison

XDJP.L has a 0.09% expense ratio, which is lower than XGEN.DE's 0.30% expense ratio.

Dividends

XDJP.L vs. XGEN.DE - Dividend Comparison

XDJP.L's dividend yield for the trailing twelve months is around 1.04%, while XGEN.DE has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
XDJP.L Xtrackers Nikkei 225 UCITS ETF 1D	1.04%	1.33%	1.41%	1.59%	2.47%	1.20%	1.11%	1.13%	1.24%	0.72%	0.83%	0.16%
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both XDJP.L and XGEN.DE in my portfolio?

XDJP.L and XGEN.DE have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, XDJP.L or XGEN.DE?

On fees, XDJP.L is cheaper at 0.09% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, XDJP.L or XGEN.DE?

XDJP.L is cheaper with a 0.09% expense ratio, compared with 0.30% for XGEN.DE.

What is the main difference between XDJP.L and XGEN.DE?

XDJP.L is categorized as Japan Equities, while XGEN.DE is Health & Biotech Equities. XDJP.L tracks TOPIX TR JPY, while XGEN.DE tracks MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. Their fees differ too: 0.09% for XDJP.L and 0.30% for XGEN.DE.